Vaccines for Enteric Diseases

8-10 July 2015, The Royal College of Physicians of Edinburgh, Edinburgh, UK

  • Increase font size
  • Default font size
  • Decrease font size

Poster Session

Poster 101
‘Serum bactericidal assay for the evaluation of typhoid vaccine using a semi-automated colony-counting method’
Jae Seung Yang et al. (International Vaccine Institute, Seoul, Republic of Korea)

Poster 102
‘Serum anti-rotavirus IgA as a measure of rotavirus exposure in unvaccinated infants from Malawi’
Aisleen Bennett et al. (Malawi-Liverpool-Wellcome Trust, Blantyre, Malawi)

Poster 103
‘Cross-reactivity of antibody responses to colonisation factors after immunisation with a multivalent enterotoxigenic Escherchia coli (ETEC) vaccine’
Susannah Leach et al. (University of Gothenburg, Gothenburg, Sweden)

Poster 104
‘Development of a serum bactericidal assay to determine functional antibody response following vaccination against Campylobacter jejuni
Joanna E. Rimmer et al. (NMRC, Silver Spring, Maryland, USA)

Poster 105
‘Plasmablast responses induced by oral enterotoxigenic Escherchia coli (ETEC) vaccination’
Ana Cardeno and Anna Lundgren (University of Gothenburg, Gothenburg, Sweden)

Poster 106
‘Functional capacity of anti-Salmonella flagellin antibodies’
Sharon M. Tennant et al. (University of Maryland School of Medicine, Baltimore, Maryland, USA)

Poster 107
‘Reactogenicity of Salmonella Newport flagellin prevents its use as a carrier protein in a Salmonella Group C conjugate vaccine’
Fabien J. Fuche et al. (University of Maryland School of Medicine, Baltimore, Maryland, USA)

Poster 108
‘Nutrition and diarrhoea in children under age five in Tanzania: Evidence from the DHS’
Melinda Judge et al. (University of Western Australia, Perth, Australia)

Poster 109
‘Down regulation of the gut inflammation in shigellosis with polypropyletherimine dendrimer glucosamine (PETIM-DG), a non-antibiotic based drug’
Dilara Islam et al. (AFRIMS, Bangkok, Thailand)

Poster 110
‘Oral vaccination with live-attenuated Salmonella (Ty21a) generates polyfunctional vaccine and heterologous cellular immune responses at the human intestinal mucosa’
Melita A. Gordon et al. (University of Liverpool, Liverpool, UK)

Poster 111
‘Increased severity in patients presenting to hospital with diarrhea in Dhaka, Bangladesh’
Fahima Chowdhury et al. (ICDDR, Dhaka, Bangladesh)

Poster 112
‘Development of a nested Real-Time multiplex PCR for the typing of enteric pathogens: Application to Campylobacter jejuni capsule typing’
Frederic Poly et al. (NMRC, Silver Spring, Maryland, USA)

Poster 113
‘The household economic burden of rotavirus hospitalization among children <5 years of age in selected hospitals in Bangladesh’
Jahangir A.M. Khan et al. (ICDDR, Dhaka, Bangladesh)

Poster 114
‘Hospital-based surveillance for severe rotavirus gastroenteritis among young children in Bangladesh: Defining the potential impact of a rotavirus vaccine program’
Syed M Satter et al. (ICDDR, Dhaka, Bangladesh)

Poster 115
‘Clinical features and molecular epidemiology of pediatric norovirus infections in Lusaka Province, Zambia’
Innocent Mwape et al. (CIDRZ, Lusaka, Zambia)

Poster 116
‘Cholera and pregnancy’
Iza Ciglenecki et al. (Medecins Sans Frontieres, Geneva, Switzerland)

Poster 117
‘Association of maternal immunity to rotavirus vaccine immunogenicity in Zambian infants’
Roma Chilengi et al. (CIDRZ, Lusaka, Zambia)

Poster 118
‘Seasonal variations in anti-rotavirus serum IgA antibody titre in Zambian infants’
Michelo Simuyandi et al. (CIDRZ, Lusaka, Zambia)

Poster 119
‘Development and preclinical evaluation of tmLT, a 3rd generation heat-labile toxin derived vaccine adjuvant’
Jacob P. Bitoun et al. (Tulane University school of Medicine, New Orleans, Louisiana, USA)

Poster 120
‘Prevalence and genetic diversity of sapoviruses in children hospitalised with gastroenteritis in South Africa’
Tanya Y. Murray et al. (University of Pretoria, Pretoria, South Africa)

Poster 121
‘Host genetic susceptibility to enteric viruses: A systematic review and meta-analysis’
Anita Kambhampati et al. (Centers for Disease Control and Prevention, Atlanta, Georgia, USA)

Poster 122
‘Inhibitory effect of pre-existing rotavirus serum IgG and IgA to live oral rotavirus vaccine in South African infants’
Sung-Sil Moon et al. (Centers for Disease Control and Prevention, Atlanta, Georgia, USA)

Poster 123
‘Global age distribution of pediatric norovirus cases’
Kayoko Shioda et al. (Centers for Disease Control and Prevention, Atlanta, Georgia, USA)

Poster 124
‘Cost-effectiveness of monovalent rotavirus vaccination in Malawi: A ground-up costed cohort study’
Naor Bar-Zeev et al. (Malawi-Liverpool-Wellcome Trust, Blantyre, Malawi)

Poster 125
‘Adjusting for age and time-dependent fluctuations in rotavirus testing when assessing the effect of rotavirus immunization in children <5 years of age’
Khitam Muhsen et al. (Tel Aviv University, Tel Aviv, Israel)

Poster 126
‘Invasive non-typhoidal Salmonella infection and P. falciparum malaria: Epidemiology in sub-Saharan Africa’
Se Eun Park et al. (International Vaccine Institute, Seoul, Republic of Korea)

Poster 127
‘Incidence of norovirus-associated medical encounters among active duty United States military personnel and their dependent beneficiaries’
Brian Rha et al. (Centers for Disease Control and Prevention, Atlanta, Georgia, USA)

Poster 128
‘Variations of invasive Salmonella infections by population size in Asante Akim North Municipal, Ghana’
Ligia Maria Cruz Espinoza et al. (International Vaccine Institute, Seoul, Republic of Korea)

Poster 129
‘Immunomodulation by Shigella outer membrane vesicles: A comparative study between SOMVs and MOMVs’
Hemanta Koley et al. (National Institute of Cholera and Enteric Diseases, Kolkata, India)

Poster 130
‘Functional antibodies against Shigella and their association with protection against disease in humans’
Avital A. Shimanovich et al. (University of Maryland, Baltimore, Maryland, USA)

Poster 131
‘Preventing cholera introduction using oral vaccines’
Joseph A. Lewnard et al. (Yale School of Public Health, New Haven, Connecticut, USA)

Poster 132
‘Dietary rice bran protects against viral gastroenteritis through preserving intestine homeostasis and promoting growth of diarrhea-reducing probiotic bacteria in gnotobiotic pigs’
Lijuan Yuan et al. (VPI & State University, Blacksburg, Virginia, USA)

Poster 133
‘Carriers of invasive salmonellosis – results from two TSAP sites: Senegal and Guinea Bissau’
Justin Im et al. (International Vaccine Institute, Seoul, Republic of Korea)

Poster 134
‘Comparative study and efficacy of a live Salmonella Gallinarum vaccine candidate secreting and adjuvant protein with SG9R in chickens’
John Hwa Lee (Chonbuk National University, Jeonju, Republic of Korea)

Poster 135
‘A safe Salmonella Gallinarum vaccine candidate that secretes an adjuvant protein with immunogenicity and protective efficacy against fowl typhoid’
John Hwa Lee (Chonbuk National University, Jeonju, Republic of Korea)

Poster 136
‘Travellers’ diarrhoea epidemiology and field site development at the British Army Training Unit in Kenya: A focus on ETEC’
Patrick Connor et al. (Royal Centre for Defence Medicine, Birmingham, UK)

Poster 137
‘IDCRP TRAVMIL: Traveller’s diarrhea and other infectious disease risk assessment, outcomes, and prevention strategies among U.S. Department of Defense beneficiaries’
David Tribble et al. (Uniformed Services University of Health Sciences, Bethesda, Maryland, USA)

Poster 138
‘Molecular re-analysis of community burdens of diarrhea in children in developing countries in the multisite MAL-ED cohort study’
James A. Platts-Mills et al. (University of Virginia, Charlottesville, Virginia, USA)

Poster 139
‘Cost-effectiveness of traveller’s diarrhea vaccination’
Richard Rheingans et al. (University of Florida, Gainesville, Florida, USA)

Poster 140
‘Engineering of a live-attenuated Salmonella enterica serovar Paratyphi B vaccine’
Ellen E. Higginson et al. (Univerity of Maryland School of Medicine, Baltimore, Maryland, USA)

Poster 141
‘Combined enterotoxigenic Escherchia coli (ETEC) – Campylobacter jejuni conjugate vaccines: A platform for multivalent vaccines against enteric pathogens’
Nelum Dorabawila et al. (NMRC, Silver Spring, Maryland, USA)

Poster 142
‘Impact of co-infections on rotavirus vaccine efficacy in a clinical trial of rotavirus vaccination (PROVIDE)’
Eric Houpt et al. (University of Virginia, Charlottesville, Virginia, USA)

Poster 143
‘Development of safe and non-self immunogenic mucosal adjuvant by recombinant fusion of cholera toxin A1 subunit with protein transduction domain’
Man Ki Song et al. (International Vaccine Institute, Seoul, Republic of Korea)

Poster 144
‘Mapping rotavirus vaccine immunologic correlates of protection to clinical outcomes’
Ross Colgate et al. (University of Vermont, Burlington, Vermont, USA)

 

VED 2015 Sponsors

  • Matrivax
  • NatureGeneTherapy.com
  • PATH
  • Aldevron
  • Takeda
  • Eveliqure
  • DNAvaccine.com
  • BioVaxx
  • hVIVO
  • Vaccine Research Center
  • Sanofi Pasteur
  • GlycoVaxyn

VED 2015 Downloads

VED 2015 Leaflet

VED 2015 Mailing List

Name
E-mail Address
What is 6+3-1?